Amicus Therapeutics Inc Cash Flow Reinvestment Rate
Amicus Therapeutics Inc cash flow reinvestment rate. Amicus Therapeutics Inc (FOLD) has a Cash Flow Reinvestment Rate of 0.40x as of December 2025, reinvesting $6.49 Million (capex $299.00K plus investments $-6.20 Million) from operating cash flow of $16.25 Million. Explore FOLD cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Amicus Therapeutics Inc (2007–2025)
Cash flow reinvestment rate of Amicus Therapeutics Inc from 2007 to 2025. Historical reinvestment intensity for Amicus Therapeutics Inc across 2 annual periods. Explore Amicus Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Amicus Therapeutics Inc Cash Flow Reinvestment Rate by Year (2007–2025)
Amicus Therapeutics Inc cash flow reinvestment rate by year from 2007 to 2025. Year-by-year capital reinvestment analysis for Amicus Therapeutics Inc. For the full cash flow conversion analysis, see cash flow conversion of Amicus Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.40x | $46.43 Million | $33.15 Million | $3.30 Million | ▲ +3081.2% |
| 2007 | 0.04x | $669.00K | $15.19 Million | $669.00K | — |